Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
about
Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanismsOxidized phospholipids and lipoprotein-associated phospholipase A2 as important determinants of Lp(a) functionality and pathophysiological roleGeneration and biological activities of oxidized phospholipidsMeasurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association.B-cell aortic homing and atheroprotection depend on Id3.Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).Circulating levels of plasminogen and oxidized phospholipids bound to plasminogen distinguish between atherothrombotic and non-atherothrombotic myocardial infarction.Clinical significance of the humoral immune response to modified LDL.Oxidized low-density lipoprotein and ankle-brachial pressure index in patients with clinically evident peripheral arterial disease.Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery diseaseChanges in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate dietGranulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesionsLipoprotein(a) is associated with necrotic core progression of non-culprit coronary lesions in statin-treated patients with angina pectorisImaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directionsCopy number variation of the Lipoprotein(a) (LPA) gene is associated with coronary artery disease in a southern Han Chinese populationEnigmatic role of lipoprotein(a) in cardiovascular disease.Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus.The Dynamics of Oxidized LDL during Atherogenesis.Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.Lipoprotein autoantibodies: measurement and significance.Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study.Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trialOxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.Lipoprotein(a): an elusive cardiovascular risk factorOxidized low-density lipoprotein.Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction.PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels.Myeloperoxidase formation of PAF receptor ligands induces PAF receptor-dependent kidney injury during ethanol consumptionNoninvasive assessment of preclinical atherosclerosis.Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease.Atherosclerosis and innate immune signaling.Lipoprotein(a): Cellular Effects and Molecular MechanismsRelease and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans.Emerging applications for zebrafish as a model organism to study oxidative mechanisms and their roles in inflammation and vascular accumulation of oxidized lipidsInflammation in coronary artery disease: potential role for immunomodulatory therapy.High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans.Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.Acute and long-term effect of percutaneous coronary intervention on serially-measured oxidative, inflammatory, and coagulation biomarkers in patients with stable anginaAssociation between circulating oxidized low-density lipoprotein and incidence of the metabolic syndromeOxidized LDL and the metabolic syndrome
P2860
Q24294266-7D335824-29C1-40D6-947C-49FCAB8217D7Q26747100-981C30B6-F95E-4B49-B47B-097B683D57EFQ28389691-F62BC246-009A-4097-B68F-E96A5ED2D0C1Q30248995-5A8A0293-2DFB-4341-BEE1-5BF86BD5CB39Q30422974-522759B5-CABB-4391-BDFE-ACB716AB2D50Q33561072-F1307271-A280-433E-97DD-BBC5B0B63552Q33597486-67FBB7E0-893E-4BE7-ABF0-349C3ECC89E6Q33598770-D4066DA6-9899-4981-AF8D-525AB8EEA874Q33822842-241003F6-99F2-4B70-8F36-CB77C273AB67Q34166358-55FC38A4-06F1-431F-8096-FA342D6EAD87Q34188087-29313F57-8F9F-47A7-9F0B-B4775DAB9592Q34457373-3C2E6543-8A17-4E65-A4BB-DB5E247EC03EQ34504402-91013E0B-FB96-454B-A2E1-9E7D8061AAE4Q34518372-D5D5880E-2EA8-41F6-B2E4-BC5F5D2238E9Q34547826-4CF146A5-6BC7-4D9E-A69A-AB44A2D39C7CQ34786504-184BFE45-6F85-48D9-83BF-6D50560A8EB5Q34999753-36F7158D-2DA5-4AF5-AA7C-95B4B9E968D0Q35024665-16A16ADA-E880-465F-A250-08B5780C567BQ35130714-3E7CCBC3-C524-43CB-B382-076BBEB9ED28Q35140009-5B8C809C-A3A8-43DF-B884-B4E3F9BC49CDQ35212898-825AAC53-DF6D-42AB-9903-0E8F4AFDD93CQ35276226-31ED7A1D-14FC-4481-8EB9-B226FF1A8092Q35592510-F2243DA1-F429-4947-924E-54400B196ECAQ35746190-022B7F46-069F-4AB1-B7F5-C8E1AAE9A259Q35860737-AB92DF09-B43B-48C4-8108-DB2EF446761DQ35905628-32788A51-4684-4E4A-8A18-F7C5D92FE466Q35959143-03A26D79-4880-4C27-B6E8-FAE8105E8DD8Q36011335-9305CA75-E70E-4514-89CB-534A63063DA2Q36012908-F6830BCD-B0AD-4E0C-88BA-2EA76BF7D1C1Q36020265-09F6DC83-CB1D-4A5D-89B3-A4F6A9E387DDQ36198508-8D9B5899-7567-4916-A156-EB0C31AEACEBQ36237559-91D4A75C-99A5-47BA-BAD1-11244C846669Q36239453-CA337239-229E-4543-912A-2B8624D93360Q36252515-0BE24203-CF6D-427C-8B88-9D323705324AQ36314881-76ED75D9-1761-406D-8815-5BB58C287B4DQ36536773-931A9FE2-13A7-4A5F-9CE8-3DBC86FD9C99Q36723319-6C5199E5-3B5C-4B0D-BA9C-F702093250D3Q36739679-280CD9FD-9B13-4037-A6DE-C3075C08DB76Q36925959-CA4FCA8A-2912-45AC-B6D7-5CA6BDD10516Q37074685-6FD309D3-B156-453C-8429-AFB2D7C867D7
P2860
Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Temporal increases in plasma m ...... e of acute coronary syndromes.
@en
Temporal increases in plasma m ...... e of acute coronary syndromes.
@nl
type
label
Temporal increases in plasma m ...... e of acute coronary syndromes.
@en
Temporal increases in plasma m ...... e of acute coronary syndromes.
@nl
prefLabel
Temporal increases in plasma m ...... e of acute coronary syndromes.
@en
Temporal increases in plasma m ...... e of acute coronary syndromes.
@nl
P2093
P1476
Temporal increases in plasma m ...... e of acute coronary syndromes.
@en
P2093
Claes Bergmark
Elizabeth Miller
Jennifer Pattison
Joseph Juliano
Reinaldo W Beyer
P304
P356
10.1016/S0735-1097(02)02769-9
P407
P577
2003-02-01T00:00:00Z